loader

otcqx:dmpi

LATEST ARTICLES
OTCQX:DMPI

The Richmond Club: DelMar Pharmaceuticals

OTCQX:DMPI

FDA Grants DelMar Pharmaceuticals Orphan Drug Designation For VAL-083 In Ovarian Cancer

OTCQX:DMPI

DelMar Pharmaceuticals Updates Ongoing Phase I/II Refractory GBM Clinical Trial with VAL-083 at AACR Annual Meeting

OTCQX:DMPI

DelMar Pharmaceuticals Announces New Data Supporting the Unique Anti-cancer Mechanism of VAL-083

OTCQX:DMPI

DelMar's VAL-083 Demonstrates Promise in the Treatment of Non-Small Cell Lung Cancer and Ovarian Cancer

OTCQX:DMPI

SeeThruEquity Issues Update on DelMar Pharmaceuticals Highlighting Partnership with MD Anderson

OTCQX:DMPI

DelMar Pharmaceuticals Announces Abstract Presentations for the American Association Cancer Research Annual Meeting in April 2016

OTCQX:DMPI

DelMar Pharmaceuticals Conference Call – CEO Jeffrey Bacha on Q2 2016 Results

OTCQX:DMPI

DelMar Pharmaceuticals – Breakthrough Cancer Therapeutics

OTCQX:DMPI

DelMar Pharmaceuticals, Inc. – "Modernizing Medicines: DelMar’s Strategic Edge for VAL-083 in Oncology"

OTCQX:DMPI

StockNewsNow.com Publishes New SNNLive Video Interview With DelMar Pharmaceuticals

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES